Helicobacter Pylori specific antibodies among multiple sclerosis patients

Journal Title: Neurology Letters - Year 2022, Vol 1, Issue 1

Abstract

Background: Multiple sclerosis (MS) is one of the most common neurological diseases that occurs predominantly in young adults and more commonly in women. MS is a chronic inflammatory disease characterized by demyelinating lesions in the brain, spinal cord, and optic nerve. This study aimed to compare Helicobacter pylori infection in patients with MS and the control group.Methos: the study was case-control. And population consisted of patients referred to a neurological specialty clinic in Isfahan from 2015 to 2018, 107 cases in the case group and 107 in the control group. The case group was referred to causes such as headache, dizziness, and other diseases that had no established association with Helicobacter pylori. Case and control groups by referring to a laboratory through IgA and IgG antibodies against Helicobacter pylori were investigated.Results: The mean age in the case and control group was 32 years. The mean IgA in the case group was 17.03 and in the control group 29.25, which was statistically significant (p-value=0.001). The mean IgG in the case group was 26.53 and in the control group was 48.69 which statistically significant (P=0.001). After the adjustment of the IgA and IgG levels on the variables such as age, gender, smoking, and history of autoimmune disease, there was a significant difference between the two groups (P-value=0.001) and in the control group, the IgA level was 11.42 and IgG levels were 21.2 points higher than the control group.Conclusion: Generally. The results of this study showed that serum IgA and IgG antibodies in the control group were more than in the case group and there was a negative correlation between Helicobacter pylori infection and MS, and according to previous studies, the results of this study suggest that Helicobacter pylori infection has a protective role in the pathogenesis of MS. 

Authors and Affiliations

Seyed-Amirabbas Ahadiat,Seyed-Ali Masoud,Mohammad sadegh khorshidi,Zeinab Hosseinian,Alireza Namvari,

Keywords

Related Articles

Neurology Letters is born!

On behalf of our editorial board, editorial team, authors, reviewers, and supporting institutions – we warmly welcome you to the first issue of the Neurology Letters. This is the official journal of the Neurology departm...

What should we do to reduce the complications of Deep brain stimulation in Parkinson's disease?

Parkinson's Disease (PD) is one of the most common neurodegenerative disorders. Recently, Deep Brain Stimulation (DBS) was proposed as a potential therapeutic approach for PD patients. This procedure has side effects tha...

Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke

Introduction: Stroke is the third most common cause of mortality and the most common disability disorder among adults. We aimed to study the relationship between Chlamydia pneumonia infection and non-cardio Ambulatory is...

Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review

Background: Cognitive dysfunction is a debilitating characteristic of multiple sclerosis (MS) that affects approximately 60% of patients. To date, the only effective treatments for cognitive decline are cognitive rehabil...

Juvenile amyotrophic lateral sclerosis in 16 years old girl with HIV

There has been demonstrated that HIV could induce the induction of Amyotrophic lateral sclerosis (ALS) syndrome. The exact mechanism of pathogenesis is not fully understood and classic ALS and HIV-associated ALS are diff...

Download PDF file
  • EP ID EP709691
  • DOI 10.52547/NL.1.1.28
  • Views 63
  • Downloads 0

How To Cite

Seyed-Amirabbas Ahadiat, Seyed-Ali Masoud, Mohammad sadegh khorshidi, Zeinab Hosseinian, Alireza Namvari, (2022). Helicobacter Pylori specific antibodies among multiple sclerosis patients. Neurology Letters, 1(1), -. https://europub.co.uk/articles/-A-709691